Inspection Record

Clarion Medical Technologies Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-12-13 3 findingsQuality unit oversightComplaint and recall handlingStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The quality control department did not evaluate the results of the annual product quality review.

2Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate. The quality control department's handling of complaints and/or information received about drug quality was inadequate.

3Stability and storage

The ongoing stability program for a drug was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-12-13. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Clarion Medical Technologies Inc. company profile — full history Health Canada documents, 2022 Go to Findings search